Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59K Hold
6,396
﹤0.01% 1596
2025
Q4
$45K Hold
6,396
﹤0.01% 1667
2025
Q3
$37K Hold
6,396
﹤0.01% 1706
2025
Q2
$31K Sell
6,396
-5,802
-48% -$33.3K ﹤0.01% 1698
2025
Q1
$106K Buy
12,198
+3,734
+44% +$39.1K ﹤0.01% 1450
2024
Q4
$103K Buy
8,464
+2,379
+39% +$33.3K ﹤0.01% 1539
2024
Q3
$102K Hold
6,085
﹤0.01% 1273
2024
Q2
$95K Buy
6,085
+1,693
+39% +$23.5K ﹤0.01% 1202
2024
Q1
$69K Hold
4,392
﹤0.01% 1341
2023
Q4
$88K Hold
4,392
﹤0.01% 1132
2023
Q3
$81K Buy
+4,392
New +$95.7K ﹤0.01% 1098
2020
Q1
Sell
-14,086
Closed -$460K 1386
2019
Q4
$460K Hold
14,086
﹤0.01% 1120
2019
Q3
$480K Hold
14,086
﹤0.01% 1092
2019
Q2
$437K Hold
14,086
﹤0.01% 1094
2019
Q1
$404K Buy
+14,086
New +$426K ﹤0.01% 1129
2018
Q2
Sell
-2,760
Closed -$92K 1318
2018
Q1
$92K Buy
+2,760
New +$83.2K ﹤0.01% 1187

Other funds holding NEOG

KBC Group's NEOG Position: Q1 2026 in Review

KBC Group held its Neogen (NEOG) position steady in Q1 2026 at 6,396 shares worth $59K. The position accounts for ﹤0.01% of the portfolio, ranked #1596.

KBC Group first reported a position in NEOG in Q1 2018 and has held it in 16 quarters since. The position peaked at $480K in Q3 2019. 307 funds tracked by Wall St. Rank hold NEOG as of Q1 2026.

  • KBC Group held 6,396 shares of Neogen worth $59K as of Q1 2026.
  • KBC Group left its Neogen share count unchanged in Q1 2026.
  • Neogen made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #1596 holding.
  • KBC Group first reported a position in Neogen in Q1 2018 and has held it in 16 quarters since.
  • KBC Group's Neogen position peaked at $480K in Q3 2019.
  • 307 funds tracked by Wall St. Rank held Neogen as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.